Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial

Nagesh Kalakonda, Marie Maerevoet, Federica Cavallo, George Follows, Andre Goy, Joost S P Vermaat, Olivier Casasnovas, Nada Hamad, Josée M Zijlstra, Sameer Bakhshi, Reda Bouabdallah, Sylvain Choquet, Ronit Gurion, Brian Hill, Ulrich Jaeger, Juan Manuel Sancho, Michael Schuster, Catherine Thieblemont, Fátima De la Cruz, Miklos Egyed, Sourav Mishra, Fritz Offner, Theodoros P Vassilakopoulos, Krzysztof Warzocha, Daniel McCarthy, Xiwen Ma, Kelly Corona, Jean-Richard Saint-Martin, Hua Chang, Yosef Landesman, Anita Joshi, Hongwei Wang, Jatin Shah, Sharon Shacham, Michael Kauffman, Eric Van Den Neste, Miguel A Canales

Open source

DOI: 10.1016/s2352-3026(20)30120-4
Published: 2020-07
Container: The Lancet Haematology
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2352-3026-20-30120-4,
  title = {Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial},
  author = {Nagesh Kalakonda and Marie Maerevoet and Federica Cavallo and George Follows and Andre Goy and Joost S P Vermaat and Olivier Casasnovas and Nada Hamad and Josée M Zijlstra and Sameer Bakhshi and Reda Bouabdallah and Sylvain Choquet and Ronit Gurion and Brian Hill and Ulrich Jaeger and Juan Manuel Sancho and Michael Schuster and Catherine Thieblemont and Fátima De la Cruz and Miklos Egyed and Sourav Mishra and Fritz Offner and Theodoros P Vassilakopoulos and Krzysztof Warzocha and Daniel McCarthy and Xiwen Ma and Kelly Corona and Jean-Richard Saint-Martin and Hua Chang and Yosef Landesman and Anita Joshi and Hongwei Wang and Jatin Shah and Sharon Shacham and Michael Kauffman and Eric Van Den Neste and Miguel A Canales},
  year = {2020},
  journal = {The Lancet Haematology},
  doi = {10.1016/s2352-3026(20)30120-4},
  url = {https://doi.org/10.1016/s2352-3026(20)30120-4}
}

RIS

TY  - JOUR
TI  - Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial
AU  - Nagesh Kalakonda
AU  - Marie Maerevoet
AU  - Federica Cavallo
AU  - George Follows
AU  - Andre Goy
AU  - Joost S P Vermaat
AU  - Olivier Casasnovas
AU  - Nada Hamad
AU  - Josée M Zijlstra
AU  - Sameer Bakhshi
AU  - Reda Bouabdallah
AU  - Sylvain Choquet
AU  - Ronit Gurion
AU  - Brian Hill
AU  - Ulrich Jaeger
AU  - Juan Manuel Sancho
AU  - Michael Schuster
AU  - Catherine Thieblemont
AU  - Fátima De la Cruz
AU  - Miklos Egyed
AU  - Sourav Mishra
AU  - Fritz Offner
AU  - Theodoros P Vassilakopoulos
AU  - Krzysztof Warzocha
AU  - Daniel McCarthy
AU  - Xiwen Ma
AU  - Kelly Corona
AU  - Jean-Richard Saint-Martin
AU  - Hua Chang
AU  - Yosef Landesman
AU  - Anita Joshi
AU  - Hongwei Wang
AU  - Jatin Shah
AU  - Sharon Shacham
AU  - Michael Kauffman
AU  - Eric Van Den Neste
AU  - Miguel A Canales
PY  - 2020
JO  - The Lancet Haematology
DO  - 10.1016/s2352-3026(20)30120-4
UR  - https://doi.org/10.1016/s2352-3026(20)30120-4
ER  -

APA

Kalakonda, N., Maerevoet, M., Cavallo, F., Follows, G., Goy, A., Vermaat, J. S. P., Casasnovas, O., Hamad, N., Zijlstra, J. M., Bakhshi, S., Bouabdallah, R., Choquet, S., Gurion, R., Hill, B., Jaeger, U., Sancho, J. M., Schuster, M., Thieblemont, C., Cruz, F. D. L., Egyed, M., Mishra, S., Offner, F., Vassilakopoulos, T. P., Warzocha, K., McCarthy, D., Ma, X., Corona, K., Saint-Martin, J., Chang, H., Landesman, Y., Joshi, A., Wang, H., Shah, J., Shacham, S., Kauffman, M., Neste, E. V. D., & Canales, M. A. (2020). Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial. The Lancet Haematology. https://doi.org/10.1016/s2352-3026(20)30120-4

Source records

crossref · retrieved 2026-09-27T08:54:09.850Z